Изменения иммунной системы в патогенезе нейрофиброматоза 1-го типаNeurofibromatosis type 1 (NF1) is a hereditary tumor syndrome occurring with a
frequency of 1: 3000
», «treatment», «
frequency», «prevalence», «genotype-phenotype correlation», « modifier genes». Results
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) of the researched alleles were found with different
frequencies among cases and controls; however, our data indicate
Parfenova, L.V.,
Galimshina, Z.R.,
Gil'fanova, G.U.,
Alibaeva, E.I.,
Danilko, K.V.,
Pashkova, T.M.,
Kartashova, O.L.,
Farrakhov, R.G.,
Mukaeva, V.R.,
Parfenov, E.V.,
Nagumothu, R.,
Valiev, R.Z. (2022) derivatives of a
natural polymer matrix – hyaluronic acid, for modification of the surface of nanostructured
Ahmad, S.,
Abbas, M.,
Ullah, M.F.,
Aziz, M.H.,
Beylerli, O.,
Alam, M.A.,
Syed, M.A.,
Uddin, S.,
Ahmad, A. (2022) suppression of EMT. NKILA is also a target of
natural anticancer compounds. Given the importance of NF-κB as a